FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and medicine and deals with application of trecresan as medication, which modulates concentration of ferritin in blood serum.
EFFECT: medication has high efficiency.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION MODULATING FERRITIN CONCENTRATION IN BLOOD SERUM | 2020 |
|
RU2749347C1 |
AGENT INCREASING FERRITIN CONCENTRATION IN HUMAN BLOOD SERUM | 2022 |
|
RU2794847C1 |
MEDIATION INCREASING LEVEL OF LACTOFERRIN IN ORGANISM | 2012 |
|
RU2486894C1 |
A MEANS OF INCREASING THE LEVEL OF LACTOFERRIN IN THE BODY | 2020 |
|
RU2744757C1 |
AGENT TO DECREASE CHOLESTEROL ESTERASE ACTIVITY | 2010 |
|
RU2444357C1 |
AGENT MODULATING ACID PHOSPHOLIPASE A1 ACTIVITY | 2010 |
|
RU2445087C1 |
AGENT STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2010 |
|
RU2429836C1 |
AGENT INTENSIFYING THROMBOCYTE ACID LYPASE ACTIVITY | 2010 |
|
RU2429833C1 |
TRECRESAN APPLICATION FOR TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION AND OBESITY | 2010 |
|
RU2429832C1 |
AGENT STIMULATING PGC-1A COACTIVATOR GENE EXPRESSION | 2011 |
|
RU2460524C1 |
Authors
Dates
2013-07-10—Published
2012-05-11—Filed